Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) presents significant challenges due to its aggressive nature and limited treatment options. Focal adhesion kinase (FAK) has emerged as a critical factor promoting tumor growth and metastasis in TNBC. Despite encouraging results from preclinical and early clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Myeongjin, Hong, Sungpyo, Cho, Hyoungmin, Park, Hanbyeol, Lee, Soo-Min, Ahn, Soonkil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528299/
https://www.ncbi.nlm.nih.gov/pubmed/37754230
http://dx.doi.org/10.3390/cimb45090446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528299/
https://www.ncbi.nlm.nih.gov/pubmed/37754230
http://dx.doi.org/10.3390/cimb45090446

Ejemplares similares